Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 456
Immune Disorders Drugs 193
Cardiovascular Drugs 157
Drug Discovery 148
Infectious Diseases Drugs 132
Biopharmaceuticals 127
Endocrine and Metabolic Disorders Drugs 111
Clinical Trials 107
Central Nervous System Drugs 105
Musculoskeletal Disorders Drugs 96
Pharmaceuticals 95
Leukemia Drugs 80
Hematological Drugs 77
Liver and Kidney Disorders Drugs 75
Lymphoma Drugs 62
Diabetes Drugs 57
Dermatological Drugs 57
Skin Cancer Drugs 48
Brain Cancer Drugs 46
Respiratory Drugs 45
Mental Disorders Drugs 43
Lung Cancer Drugs 39
Gastrointestinal Drugs 38
Pharmaceutical Intermediates 34
Drug Delivery 34
Immunosuppressive Drugs 33
Pharmaceutical Manufacturing 31
Infusions and Injectables 30
Liver Cancer Drugs 29
Analgesics 27
Antibiotics 26
Bladder Cancer Drugs 25
Drugs by Therapeutic Area 23
Kidney Cancer Drugs 21
Pancreatic Cancer Drugs 19
Prostate Cancer Drugs 18
Urological Disorders Drugs 18
Colon Cancer Drugs 17
HIV/AIDS Drugs 17
Schizophrenia Drugs 17
Cervical Cancer Drugs 16
Sexual and Reproductive Health Drugs 16
Ovarian Cancer Drugs 15
Thyroid Cancer Drugs 14
Breast Cancer Drugs 13
Cancer Vaccines 13
Psoriasis Drugs 12
Over the Counter (OTC) Drugs 11
Biosimilars and Biosuperiors 11
Generic Drugs 10
Anti-Obesity Drugs 9
Optical Disorders Drugs 8
Vaccines 8
Transdermal and Transmucosal Drug Delivery 7
Alzheimer's Disease Drugs 7
Uterine Cancer Drugs 6
Company Reports 5
Cough and Cold Drugs 5
Anxiety Drugs 4
Pharmacoeconomics 3
Vitamins and Dietary Supplements 3
Asthma Drugs 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Allergy Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



278 reviews

2,403 Results (Page 71 of 121)
- Relevance
  Sort by

Peptide Therapeutics Market 2024-2028

 Report
June 2024
148 Pages
Global

From

€2207EUR$2,500USD£1,913GBP

Protein Therapeutics Market 2024-2028

 Report
May 2024
191 Pages
Global

From

€2207EUR$2,500USD£1,913GBP

Pulmonary Embolism Therapeutics Market 2025-2029

 Report
June 2025
206 Pages
Global

From

€2207EUR$2,500USD£1,913GBP

Global CD19 Antibody Market & Clinical Pipeline Outlook 2028

 Report
October 2023
420 Pages
Global

From

€2305EUR$2,610USD£1,998GBP

€2561EUR$2,900USD£2,220GBP

Immunomodulator Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
August 2023
102 Pages
Global

From

€3500EUR$4,246USD£3,140GBP

NEED HELP FINDING THE RIGHT PRODUCT? Brian will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Germany OTC Drug - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)

 Report
July 2024
80 Pages
Germany

From

€4194EUR$4,750USD£3,635GBP

Pancreatic Cancer - Market Insight, Epidemiology And Market Forecast - 2032

 Report
August 2022
285 Pages
Global

From

€8388EUR$9,500USD£7,271GBP

T-Cell Lymphoma Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 to 2029

 Report
September 2021
102 Pages
Global

From

€3973EUR$4,500USD£3,444GBP

Addison's Disease Therapeutics - Global Strategic Business Report

 Report
August 2025
278 Pages
Global

From

€5165EUR$5,850USD£4,477GBP

Fibroblast Growth Factors - Global Strategic Business Report

 Report
August 2025
486 Pages
Global

From

€5165EUR$5,850USD£4,477GBP

Insulin Sensitizers - Global Strategic Business Report

 Report
August 2025
340 Pages
Global

From

€5165EUR$5,850USD£4,477GBP

Hypoparathyroidism Treatment - Global Strategic Business Report

 Report
August 2025
369 Pages
Global

From

€5165EUR$5,850USD£4,477GBP

Metabolic Disorder Therapeutics - Global Strategic Business Report

 Report
August 2025
286 Pages
Global

From

€5165EUR$5,850USD£4,477GBP

Dermatological Therapeutics Market by Therapy Type (Injectable, Systemic, Topical), Indication (Acne, Bacterial Infection, Eczema), Formulation, Route Of Administration, Distribution Channel, End User - Global Forecast 2025-2030

 Report
August 2025
194 Pages
Global

From

€3130EUR$3,545USD£2,713GBP

€3478EUR$3,939USD£3,015GBP

Dermatological Drugs Market 2025-2033

 Report
March 2025
138 Pages
Global

From

€2648EUR$2,999USD£2,295GBP

Therapeutic Antibody Market (2023 Edition): Analysis By Antibody Type (Monoclonal, Bispecific, Drug Conjugates, Others), Source (Fully human, Humanized, Others), By Application, By Region, By Country: Market Insights and Forecast (2019-2029)

 Report
February 2024
260 Pages
Global

From

€2163EUR$2,450USD£1,875GBP

Global Markets for Bioengineered Protein Drugs

 Report
March 2023
185 Pages
Global

From

€2207EUR$2,500USD£1,913GBP

Cardiovascular Therapeutics Market 2025-2029

 Report
March 2025
219 Pages
Global

From

€2207EUR$2,500USD£1,913GBP

Vitiligo Treatment Market, Size, Share, Global Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis

 Report
August 2023
250 Pages
Global

From

€1757EUR$1,990USD£1,523GBP

Heparin Market by Product Type, Source, Administration Routes, Application, End Users, Distribution Channel - Global Forecast 2025-2030

 Report
August 2025
187 Pages
Global

From

€3130EUR$3,545USD£2,713GBP

€3478EUR$3,939USD£3,015GBP

2,403 Results (Page 71 of 121)
- 1
- 69
- 70
- 71
- 72
- 73

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.